Literature DB >> 28050863

Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis.

Amjad M Ahmed1, Waqas T Qureshi2, Wesley T O'Neal2, Fatima Khalid2, Mouaz H Al-Mallah3,4,5,6.   

Abstract

BACKGROUND: Traditional cardiovascular (CV) risk factors have limited predictive value of CV mortality in patients with chronic kidney disease (CKD, creatinine clearance less than 60 mL/minute per 1.73 m2). The aim of this study was to evaluate incremental and independent prognostic value of single-photon emission computerized tomography-myocardial perfusion imaging (SPECT-MPI) across continuum of renal function.
METHODS: We retrospectively studied 11,518 (mean age, 65 ± 12 years; 52% were men) patients referred for a clinical indication of SPECT-MPI between April 2004 and May 2009. Primary end point was composite of cardiac death and non-fatal myocardial infarction (CD/MI). We examined the relationship of total perfusion defect (TPD) and CD/MI in multiple Cox regression models for CV risk factors and GFR. The incremental predictive value of TPD was examined using Harrell's c-index, net reclassification index (NRI), and integrated discrimination index (IDI).
RESULTS: Over a median follow-up of 5 years (25th to 75th percentiles, 3.0-6.5 years), 1,692 (14.5%) patients experienced CD/MI (740 MI and 1,182 CD). In a multivariable model adjusted for traditional CV risk factors and GFR, the presence of a perfusion defect was independently associated with increased risk of CD/MI (HR = 2.10; 95% CI 1.81, 2.43, p < .001). Using Cox regression, TPD improved the discriminatory ability beyond traditional CV risk factors and GFR [from AUC = 0.725, (95% CI 0.712-0.738) to 0.784, (95% CI 0.772-0.796), p < .0001]. Furthermore, TPD improves risk stratification of CKD patients over and above traditional CV risk factors and GFR [NRI = 14%, 95% CI (12%-16%, p < .001) and relative IDI = 60%, 95% CI (51%, 66%, p < .001)].
CONCLUSIONS: Across the spectrum of renal function, SPECT-MPI perfusion defects independently and incrementally reclassified patients for their risk of CD/MI, beyond traditional CV risk factors.

Entities:  

Keywords:  SPECT-MPI; cardiovascular death; chronic kidney disease; myocardial infarction; perfusion defects; risk reclassification

Mesh:

Year:  2017        PMID: 28050863     DOI: 10.1007/s12350-016-0756-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  48 in total

1.  Quantitative relation of ST-segment depression during exercise to the magnitude of myocardial ischemia as assessed by single-photon emission computed tomographic myocardial perfusion imaging.

Authors:  Thomas H Hauser; Sharmila Dorbala; Abdulbaset Sulaiman; Marcelo F Di Carli
Journal:  Am J Cardiol       Date:  2004-09-15       Impact factor: 2.778

2.  Time to and risk of cardiac events after myocardial perfusion scintigraphy.

Authors:  Francesco Nudi; Giandomenico Neri; Orazio Schillaci; Annamaria Pinto; Enrica Procaccini; Maurizio Vetere; Fabrizio Tomai; Giacomo Frati; Giuseppe Biondi-Zoccai
Journal:  J Cardiol       Date:  2015-01-13       Impact factor: 3.159

3.  Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.

Authors:  Scott D Solomon; Madeline M Rice; Kathleen A Jablonski; Powell Jose; Michael Domanski; Marc Sabatine; Bernard J Gersh; Jean Rouleau; Marc A Pfeffer; Eugene Braunwald
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

4.  Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Authors:  J F Mann; H C Gerstein; J Pogue; J Bosch; S Yusuf
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

5.  Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function.

Authors:  Marc Froissart; Jerome Rossert; Christian Jacquot; Michel Paillard; Pascal Houillier
Journal:  J Am Soc Nephrol       Date:  2005-01-19       Impact factor: 10.121

6.  Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study.

Authors:  Y Arad; D Newstein; F Cadet; M Roth; A D Guerci
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

7.  Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.

Authors:  Francesca Mallamaci; Giovanni Tripepi; Sebastiano Cutrupi; Lorenzo S Malatino; Carmine Zoccali
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

8.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for patients with diabetes and chronic kidney disease.

Authors:  Chio Okuyama; Kenichi Nakajima; Tsuguru Hatta; Shigeyuki Nishimura; Hideo Kusuoka; Akira Yamashina; Tsunehiko Nishimura
Journal:  Nucl Med Commun       Date:  2011-10       Impact factor: 1.690

9.  Comparative prognostic value of automatic quantitative analysis versus semiquantitative visual analysis of exercise myocardial perfusion single-photon emission computed tomography.

Authors:  D S Berman; X Kang; K F Van Train; H C Lewin; I Cohen; J Areeda; J D Friedman; G Germano; L J Shaw; R Hachamovitch
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

10.  Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency.

Authors:  Marcello Tonelli; Lemuel Moyé; Frank M Sacks; Bryce Kiberd; Gary Curhan
Journal:  Ann Intern Med       Date:  2003-01-21       Impact factor: 25.391

View more
  4 in total

Review 1.  Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: current state and future directions.

Authors:  Firas Al Badarin; Ahmed Aljizeeri; Fatimah Almasoudi; Mouaz H Al-Mallah
Journal:  Heart Fail Rev       Date:  2017-07       Impact factor: 4.214

Review 2.  Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review.

Authors:  Aviral Vij; Yasmeen Golzar; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2017-06-26       Impact factor: 5.952

Review 3.  Nuclear Cardiology in Women and Underrepresented Minority Populations.

Authors:  Renee P Bullock-Palmer; Amalia Peix; Niti R Aggarwal
Journal:  Curr Cardiol Rep       Date:  2022-03-09       Impact factor: 2.931

Review 4.  Cardiorespiratory Fitness and Cardiovascular Disease Prevention: an Update.

Authors:  Mouaz H Al-Mallah; Sherif Sakr; Ada Al-Qunaibet
Journal:  Curr Atheroscler Rep       Date:  2018-01-16       Impact factor: 5.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.